FdaApplication
ANDA 212472
Identifiers
- fda_app_no: ANDA212472
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC |
| application_type | ANDA |
| approval_date | 2022-03-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE | 20MG;20MG | TABLET, EXTENDED RELEASE;ORAL |
1 product